MedPath

Azacitidine

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for . AZACITIDINE for injection, Initial U.S. Approval: 2004

Approved
Approval ID

314faacb-45e7-332e-acc7-b9ff5a475b0c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 1, 2023

Manufacturers
FDA

Dr. Reddy's Laboratories Inc.

DUNS: 802315887

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azacitidine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-143
Application NumberANDA207234
Product Classification
M
Marketing Category
C73584
G
Generic Name
Azacitidine
Product Specifications
Route of AdministrationSUBCUTANEOUS, INTRAVENOUS
Effective DateAugust 30, 2018
FDA Product Classification

INGREDIENTS (2)

AzacitidineActive
Quantity: 100 mg in 50 mL
Code: M801H13NRU
Classification: ACTIB
mannitolInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Azacitidine - FDA Drug Approval Details